25 A retrospective analysis of patients with advanced EGFR mutated lung cancer treated with either first line erlotinib or gefitinibKiruthikah Thillai, Rohit Lal, Eleni Karapanagiotou et al.|Lung Cancer|2014Cited by 0
Chemotherapy dose density in elderly lung cancer patients requires frequent modifications: A retrospective case series from January 2011 to July 2012Sasithara Ahilathirunayagam, Rohit Lal, Tania Kalsi et al.|Journal of Geriatric Oncology|2012Cited by 0
63: Crizotinib for ALK rearrangement in non small cell lung cancerS. Merrick, Sunita Ghosh, Matthew J. Dalby et al.|Lung Cancer|2017Cited by 0
72: Treatment outcomes with tyrosine kinase inhibitors in patients with uncommon EGFR mutations in non-small cell lung cancerSarah Hunter, Eleni Karapanagiotou, James Spicer et al.|Lung Cancer|2017Cited by 0